Skip to main content
Log in

Transport of Alpha-Tocopherol and Its Derivatives Through Erythrocyte Membranes

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To investigate the transport of α-tocopherol (T), tocopherol succinate (TS) and tocopherol succinate-3-glucose (a newly synthetized, less hydrophobic T ester; TSG) through bovine erythrocyte membranes.

Methods. Our experiments were carried out on erythrocytes (obtained from heparinized fresh bovine blood), because they represent a suitable model for investigations of membrane transport.

Results. T was shown to reside almost completely in the suspension medium, while the greater part of TS disappeared from the suspension medium and was mainly incorporated into erythrocyte membranes. In comparison with T, a larger amount of TSG was incorporated into erythrocyte membranes and taken up by cells; however the TSG intra-cellular accumulation was significantly lower than that observed with TS. Furthermore, the transport of TS and TSG was partially inhibited by p-chloromercuribenzenesulfonate (which inhibits monocarboxylate uptake; PCMBS) and by maltose (a competitive inhibitor of glucose transport) respectively, with a concomitant increase in drug membrane incorporation. No significant change in drug transport was observed in the presence of 4,4′-diisothiocyanostilbene-2,2′-disulfonate, a selective and irreversible blocker of band 3 protein (DIDS).

Conclusions. Our results show 1) the existence of large differences in membrane incorporation of T, TS and TSG (very likely caused by differing abilities to fill spaces in the lipid bilayer) and 2) a specific contribution of the monocarboxylate transport protein and of the glucose transport protein in the cellular uptake of TS and TSG, respectively. A tempting suggestion is that the unique cytoprotective properties of TS may be related to the differences in the transmembrane mobility observed between T and its succinate ester. Furthermore, T conjugation to a monocarboxylate or glycoside moiety could provide suitable substrates for active membrane transport, thus appearing as a promising pharmaceutical strategy for the improved delivery of tocopherol derivatives.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. S. A. B. E. van Acker, L. M. H. Koymans, and A. Bast. Molecular pharmacology of vitamin E: structural aspects of antioxidant activity. Free Rad. Biol. Med. 15:311–328 (1993).

    Google Scholar 

  2. V. E. Kagan, E. A. Serbinova, R. A. Bakalova, Ts. S. Stoytchev, A. N. Erin, L. L. Prilipko, and R. P. Evstigneeva. Mechanism of stabilization of biomembranes by alpha-tocopherol. The role of the hydrocarbon chain in the inhibition of lipid peroxidation. Biochem. Pharmacol. 40:2403–2413 (1990).

    Google Scholar 

  3. E. Serbinova, V. Kagan, D. Han, and L. Packer. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Rad. Biol. Med. 10:263–275 (1991).

    Google Scholar 

  4. M. W. Fariss. Oxygen toxicity: unique cytoprotective properties of vitamin E succinate in hepatocytes. Free Rad. Biol. Med. 9:333–343 (1990).

    Google Scholar 

  5. A. Saija, M. Scalese, M. Lanza, D. Marzullo, F. Bonina, and F. Castelli. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Rad. Biol. Med. 19:481–6 (1995).

    Google Scholar 

  6. Y. Matsumoto, and M. Ohsako. Transport of drugs through human erythrocyte membranes: pH dependence of drug transport through labeled human erythrocytes in the presence of band 3 protein inhibitor. J. Pharm. Sci. 81:428–31 (1992).

    Google Scholar 

  7. Y. Matsumoto, M. Ohsako, A. Takadate, and S. Goto. Reduction of erythrocyte membrane permeability and protein binding of low-molecular-weight drugs following glycoside derivatization. J. Pharm. Sci. 82:399–403 (1993).

    Google Scholar 

  8. M. Mosior, W. A. Bialas, and J. Gomulkiewicz. Effect of DIDS on osmotic properties of bovine erythrocytes. Biochim. Biophys. Acta 945:51–5 (1988).

    Google Scholar 

  9. S. U. Devaskar. The mammalian brain glucose transport system. In M.K. Raizada, and D. LeRoith (eds.), Molecular Biology and Physiology of Insulin and Insulin-Like Growth Factors. Plenum-Press, New York, 1991, pp. 405–417.

    Google Scholar 

  10. R. C. Poole, and A. P. Halestrap. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am. J. Physiol. 264(Cell Physiol. 33):C761–C782 (1993).

    Google Scholar 

  11. A. Namane, C. Gouyette, M. Fillion, G. Fillion, and T. Huynh-Dinh. Improved brain delivery of AZT using a glycosyl phosphotriester prodrug. J. Med. Chem. 35:3039–3044 (1992).

    Google Scholar 

  12. J. Neuman, M. Hervé, J. Debouzy, F. I. Guerra, C. Gouyette, B. Dupraz, and T. Huynh-Dinh. Synthesis and transmembrane transport studies by NMR of a glucosyl phospholipid of thymidine. J. Am. Chem. Soc. 111:4270–4277 (1989).

    Google Scholar 

  13. I. Walker, D. Nicholls, W. J. Irwin, and S. Freeman. Drug delivery via active transport at the blood-brain barrier: affinity of a prodrug of phosphonoformate for the large amino acid transporter. Int. J. Pharm. 104:157–167 (1994).

    Google Scholar 

  14. T. Mizuma, K. Ohta, M. Hayashi, and S. Awazu. Intestinal active absorption of sugar-conjugated compounds by glucose transport system: implication of improvement of poorly absorbable drugs. Biochem. Pharmacol. 43:2037–2039 (1992).

    Google Scholar 

  15. T. Mizuma, K. Ohta, M. Hayashi, and S. Awazu. Comparative study of active absorption by the intestine and disposition of anomers of sugar-conjugated compounds. Biochem. Pharmacol. 45:1520–1523 (1993).

    Google Scholar 

  16. A. Carruthers, and A. L. Helgerson. Inhibitions of sugar transport produced by ligands binding at opposite sides of the membrane. Evidence for simultaneous occupation of the carrier by maltose and cytochalasin B. Biochem. 30:3907–15 (1991).

    Google Scholar 

  17. A. Hassner, and V. Alexanian. Direct room temperature esterI fication of carboxylic acids. Tetrahedron Lett. 46:4475–8 (1978).

    Google Scholar 

  18. G. Herrera, J. F. B. Vazquez, N. B. Iborra, and M. B. Riego Martin. Tensioactividad de productos derivados de grasas e hidratos de carbono. III. 3(6)-O-decanoil(lauroil)-D-glucosas. Grasas y Aceites 38:116–119 (1987).

    Google Scholar 

  19. M. W. Fariss, M. H. Merson, and T. M. O'Hara. Alpha-Tocopheryl succinate protects hepatocytes from chemical-induced toxicity under physiological calcium conditions. Toxicol. Lett. 47:61–75 (1989).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bonina, F., Lanza, M., Montenegro, L. et al. Transport of Alpha-Tocopherol and Its Derivatives Through Erythrocyte Membranes. Pharm Res 13, 1343–1347 (1996). https://doi.org/10.1023/A:1016017832146

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016017832146

Navigation